Isabel Graupera

ORCID: 0000-0001-9170-9784
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Organ Transplantation Techniques and Outcomes
  • Diet, Metabolism, and Disease
  • Acute Kidney Injury Research
  • Alcohol Consumption and Health Effects
  • Drug-Induced Hepatotoxicity and Protection
  • Liver Diseases and Immunity
  • Liver physiology and pathology
  • Electrolyte and hormonal disorders
  • Hepatitis B Virus Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Diabetes and associated disorders
  • Diet and metabolism studies
  • Renal function and acid-base balance
  • Hepatitis C virus research
  • Pancreatitis Pathology and Treatment
  • MicroRNA in disease regulation
  • Hormonal Regulation and Hypertension
  • Nutrition and Health in Aging
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Hepatitis Viruses Studies and Epidemiology
  • Cardiovascular Disease and Adiposity
  • Viral gastroenteritis research and epidemiology
  • Trace Elements in Health

Universitat de Barcelona
2016-2025

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
2016-2025

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
2016-2025

Hospital Clínic de Barcelona
2015-2024

Centre for Biomedical Network Research on Rare Diseases
2013-2024

Harvard University
2023

Fundació Clínic per a la Recerca Biomèdica
2023

Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer
2023

Odense University Hospital
2023

Hospital General Universitario Gregorio Marañón
2023

The hemoglobin threshold for transfusion of red cells in patients with acute gastrointestinal bleeding is controversial. We compared the efficacy and safety a restrictive strategy those liberal strategy.

10.1056/nejmoa1211801 article EN New England Journal of Medicine 2013-01-03
Zobair M. Younossi Vlad Ratziu Rohit Loomba Mary E. Rinella Quentin M. Anstee and 95 more Zachary Goodman Pierre Bédossa Andreas Geier Susanne Beckebaum Philip N. Newsome David Sheridan Muhammad Y. Sheikh James F. Trotter W Knapple Eric Lawitz Manal F. Abdelmalek Kris V. Kowdley Aldo J. Montaño‐Loza Jérôme Boursier Philippe Mathurin Elisabetta Bugianesi G. Mazzella Antonio Olveira Helena Cortez‐Pinto Isabel Graupera David Orr Lise Lotte Gluud Jean‐François Dufour David E. Shapiro Jason Campagna Luna Zaru Leigh MacConell Reshma Shringarpure Stephen A. Harrison Arun J. Sanyal Manal F. Abdelmalek Gary A. Abrams Humberto Aguilar Aijaz Ahmed Elmar Aigner Guruprasad P. Aithal Aftab Ala William Alazawi Agustı́n Albillos Michael Allison Sfa Al-Shamma Raúl J. Andrade Pietro Andreoné M. Angélico Victor Ankoma‐Sey Quentin M. Anstee Rodolphe Anty Víctor Araya Juan Ignacio Arenas Ruiz Perttu Arkkila Marty Arora Tarik Asselah Jennifer Au Oyekoya T. Ayonrinde Robert J. Bailey Maya Balakrishnan Kiran Bambha Meena B. Bansal Sidney Barritt John Bate Jorge Beato Susanne Beckebaum Jaideep Behari Pablo Bellot Ziv Ben Ari Michael Bennett Marina Berenguer Benedetta Terziroli Beretta‐Piccoli Thomas Berg Maurizio Bonacini Lucía Bonet Brian B. Borg Marc Bourlière Jérôme Boursier William D. Bowman David Bradley Marija Branković Marius Braun Jean-Pierre Bronowicki Savino Bruno Elisabetta Bugianesi Cindy X. Cai Amy Calderon José Luís Calleja Elizabeth J. Carey Michal Carmiel J.A. Carrión Matthew C. Cave Cristina Chagas Tawfik N. Chami Alan K. Chang Allan Coates Jeremy Cobbold Charlote Costentin Kathleen E. Corey

10.1016/s0140-6736(19)33041-7 article EN The Lancet 2019-12-01

Background & AimsLiver fibrosis is the main determinant of long-term outcome in chronic liver diseases. Little known about prevalence general population. The aim study was to investigate adult population with unknown disease.MethodsThis a population-based, cross-sectional performed Barcelona metropolitan area. Subjects aged 18 75 years old were identified randomly from citizens included primary health care registry. Of 4866 subjects invited, 3076 participated (63.2%). Liver estimated by...

10.1016/j.cgh.2017.12.048 article EN cc-by-nc-nd Clinical Gastroenterology and Hepatology 2018-02-13

Fibrosis-4 (FIB-4) and the nonalcoholic fatty liver disease fibrosis score (NFS) are 2 most popular noninvasive blood-based serum tests proposed for widespread screening. We therefore aimed to describe accuracy of FIB-4 NFS detect elevated stiffness as an indicator hepatic in low-prevalence populations.This study included a total 5129 patients with concomitant measurement FIB-4, NFS, (LSM) by Fibroscan (Echosens, France) from 5 independent population-based cohorts Spain, Hong Kong, Denmark,...

10.1016/j.cgh.2021.12.034 article EN cc-by Clinical Gastroenterology and Hepatology 2021-12-29
Miquel Serra‐Burriel Adrià Juanola Feliu Serra-Burriel Maja Thiele Isabel Graupera and 95 more Elisa Pose Guillem Pera Ivica Grgurević Llorenç Caballería Salvatore Piano Laurens van Kleef Mathias Reichert Dominique Roulot Juan M. Pericàs Jörn M. Schattenberg Emmanuel A Tsochatztis Indra Neil Guha Montserrat García‐Retortillo Rosario Hernández Jordi Hoyo Matilde Fuentes Carmen Barranco Expósito Alba Martínez-Escudé Patricia Such Anita Madir Sönke Detlefsen Marta Tonon Andréa Martini Ann T. Judith Pich Eva Bonfill Marta Juan Anna Soria Marta Carol Jordi Gratacós‐Ginès Rosa M. Morillas Pere Torán‐Monserrat J. M. Navarrete Antoni Torrejón Céline Fournier Anne Llorca Anita Arslanow Harry J. de Koning Fernando Cucchietti Michael P. Manns Philip N. Newsome Rubén Hernáez Alina M. Allen Paolo Angeli Robert J. de Knegt Tom H. Karlsen Peter R. Galle Vincent Wai‐Sun Wong Núria Fabrellas Laurent Castéra Aleksander Krag Frank Lammert Patrick S. Kamath Pere Ginés Marifé Alvarez Peter Andersen Paolo Angeli Alba Ardèvol Anita Arslanow Luca Beggiato Zahia Ben Abdesselam Lucy Bennett Bajiha Boutouria Alessandra Brocca M. Teresa Broquetas Llorenç Caballería Valeria Calvino Judith Camacho Aura Capdevila Marta Carol Laurent Castéra Marta Cervera Fernando Cucchietti Anna de Fuentes Rob de Knegt Harry J. de Koning Sönke Detlefsen Alba Díaz José Diéguez Bande Vanessa Esnault Núria Fabrellas Josep Lluis Falcó Rosa Fernández Céline Fournier Matilde Fuentes Peter R. Galle Edgar García Montserrat García‐Retortillo E.A González Garrido Pere Ginés Rosa Gordillo Medina Jordi Gratacós‐Ginès Isabel Graupera Ivica Grgurević Indra Neil Guha

10.1016/s0140-6736(23)01174-1 article EN The Lancet 2023-08-09

Kidney biomarkers appear to be useful in differential diagnosis between acute tubular necrosis (ATN) and other types of kidney injury (AKI) cirrhosis, particularly hepatorenal syndrome (HRS‐AKI). Distinction is important because treatment different. However, are still not used clinical practice. The aim the current study was investigate accuracy several AKI predicting outcome patient survival. This a prospective 320 consecutive cases patients hospitalized for decompensated cirrhosis....

10.1002/hep.30592 article EN Hepatology 2019-02-27

Cirrhosis is associated with changes in gut microbiome composition. Although acute-on-chronic liver failure (ACLF) the most severe clinical stage of cirrhosis, there lack information about alterations ACLF using quantitative metagenomics. We investigated patients cirrhosis encompassing whole spectrum disease (compensated, acutely decompensated without ACLF, and ACLF). A group healthy subjects was used as control subjects.Stool samples were collected prospectively 182 cirrhosis. DNA library...

10.1053/j.gastro.2020.08.054 article EN cc-by-nc-nd Gastroenterology 2020-09-14

Abstract ACLF is characterized by a systemic inflammatory response, but the cytokines involved in this process have not been well studied. The aim of study was to characterize response patients with cirrhosis and its relationship prognosis. Fifty-five cirrhosis, 26 ACLF, were studied prospectively. Systemic analyzed measuring large array plasma using multiplex kit. A principal component analysis show noticeable differences between decompensated without ACLF. Patients had significant abnormal...

10.1038/srep32341 article EN cc-by Scientific Reports 2016-08-31

Background Biomarkers are potentially useful in assessment of outcomes patients with cirrhosis, but information is very limited. Given the large number biomarkers, adequate choice which biomarker(s) to investigate first important. Aim Analysis potential usefulness a panel urinary biomarkers outcome cirrhosis. Patients and Methods Fifty-five acute decompensation cirrhosis were studied: 39 had Acute Kidney Injury (AKI) (Prerenal 12, type-1 HRS (hepatorenal syndrome) 15 Tubular Necrosis (ATN)...

10.1371/journal.pone.0128145 article EN cc-by PLoS ONE 2015-06-04

<h3>Objective</h3> MicroRNAs (miRNAs) are well-known regulators of disease pathogenesis and have great potential as biomarkers therapeutic targets. We aimed at profiling miRNAs in alcoholic hepatitis (AH) identifying potentially involved liver injury. <h3>Design</h3> MiRNA was performed samples from patients with AH, alcohol disease, non-alcoholic steatohepatitis, HCV normal tissue. Expression assessed serum AH animal models. Mimic decoy miR-182 were used vitro vivo to evaluate miR-1829s...

10.1136/gutjnl-2015-311314 article EN Gut 2016-05-10
Coming Soon ...